# SLR Investment Corp.: financial statements, quarterly

SLRC · Nasdaq · CIK 1418076 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/slrc.md) · [Financials](/companies/slrc/financials.md) · [Filings](/companies/slrc/filings.md) · [Insiders](/companies/slrc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/slrc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [19.9](/filings/0000950170-24-122234.md) | [19.5 d](/filings/0001193125-26-066979.md) | [18.2](/filings/0000950170-25-065626.md) | [18.2](/filings/0000950170-25-103004.md) | [18.9](/filings/0001193125-25-264654.md) | [16.2 d](/filings/0001193125-26-066979.md) | [15.8](/filings/0001193125-26-206311.md) | [16.7](/filings/0001193125-26-332726.md) | [18.7](/filings/0001193125-25-264654.md) | [16.6 d](/filings/0001193125-26-066979.md) | [16.4](/filings/0001193125-26-206311.md) | [16.8](/filings/0001193125-26-332726.md) |
| Net income | $m | [26.9](/filings/0000950170-24-122234.md) | [23.6 d](/filings/0001193125-26-066979.md) | [27.9](/filings/0000950170-25-065626.md) | [23.2](/filings/0000950170-25-103004.md) | [22.0](/filings/0001193125-25-264654.md) | [22.6 d](/filings/0001193125-26-066979.md) | [19.9](/filings/0001193125-26-206311.md) | [24.2](/filings/0001193125-26-332726.md) | [23.3](/filings/0001193125-25-264654.md) | [25.1 d](/filings/0001193125-26-066979.md) | [17.1](/filings/0001193125-26-206311.md) | [8.3](/filings/0001193125-26-332726.md) |
| Diluted EPS | $ per share | [0.49](/filings/0000950170-24-122234.md) | not reported | [0.51](/filings/0000950170-25-065626.md) | [0.43](/filings/0000950170-25-103004.md) | [0.40](/filings/0001193125-25-264654.md) | not reported | [0.37](/filings/0001193125-26-206311.md) | [0.44](/filings/0001193125-26-332726.md) | [0.43](/filings/0001193125-25-264654.md) | not reported | [0.31](/filings/0001193125-26-206311.md) | [0.15](/filings/0001193125-26-332726.md) |
| Basic EPS | $ per share | [0.49](/filings/0000950170-24-122234.md) | not reported | [0.51](/filings/0000950170-25-065626.md) | [0.43](/filings/0000950170-25-103004.md) | [0.40](/filings/0001193125-25-264654.md) | not reported | [0.37](/filings/0001193125-26-206311.md) | [0.44](/filings/0001193125-26-332726.md) | [0.43](/filings/0001193125-25-264654.md) | not reported | [0.31](/filings/0001193125-26-206311.md) | [0.15](/filings/0001193125-26-332726.md) |

- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [10.3](/filings/0001193125-23-272454.md) | [11.9](/filings/0000950170-25-026605.md) | [15.3](/filings/0001193125-24-134205.md) | [11.0](/filings/0000950170-24-092748.md) | [23.0](/filings/0000950170-24-122234.md) | [16.8](/filings/0001193125-26-066979.md) | [19.9](/filings/0000950170-25-065626.md) | [23.9](/filings/0000950170-25-103004.md) | [21.4](/filings/0001193125-25-264654.md) | [15.7](/filings/0001193125-26-332726.md) | [11.2](/filings/0001193125-26-206311.md) | [24.4](/filings/0001193125-26-332726.md) |
| Total assets | $m | [2,539](/filings/0001193125-23-272454.md) | [2,524](/filings/0000950170-25-026605.md) | [2,468](/filings/0001193125-24-134205.md) | [2,448](/filings/0000950170-24-092748.md) | [2,443](/filings/0000950170-24-122234.md) | [2,449](/filings/0001193125-26-066979.md) | [2,503](/filings/0000950170-25-065626.md) | [2,537](/filings/0000950170-25-103004.md) | [2,530](/filings/0001193125-25-264654.md) | [2,573](/filings/0001193125-26-332726.md) | [2,540](/filings/0001193125-26-206311.md) | [2,560](/filings/0001193125-26-332726.md) |
| Total liabilities | $m | [1,554](/filings/0001193125-23-272454.md) | [1,537](/filings/0000950170-25-026605.md) | [1,476](/filings/0001193125-24-134205.md) | [1,455](/filings/0000950170-24-092748.md) | [1,450](/filings/0000950170-24-122234.md) | [1,456](/filings/0001193125-26-066979.md) | [1,512](/filings/0000950170-25-065626.md) | [1,545](/filings/0000950170-25-103004.md) | [1,537](/filings/0001193125-25-264654.md) | [1,577](/filings/0001193125-26-332726.md) | [1,550](/filings/0001193125-26-206311.md) | [1,578](/filings/0001193125-26-332726.md) |
| Long-term debt | $m | [1,192](/filings/0001193125-23-272454.md) | [1,178](/filings/0000950170-25-026605.md) | [1,157](/filings/0001193125-24-134205.md) | [1,154](/filings/0000950170-24-092748.md) | [1,102](/filings/0000950170-24-122234.md) | [1,032](/filings/0001193125-26-066979.md) | [1,039](/filings/0000950170-25-065626.md) | [1,173](/filings/0000950170-25-103004.md) | [1,139](/filings/0001193125-25-264654.md) | [1,146](/filings/0001193125-26-332726.md) | [1,138](/filings/0001193125-26-206311.md) | [1,154](/filings/0001193125-26-332726.md) |

- Cash and equivalents: us-gaap:Cash
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [39.4 d](/filings/0000950170-24-122234.md) | [38.2 d](/filings/0001193125-26-066979.md) | [7.3](/filings/0000950170-25-065626.md) | [2.9 d](/filings/0000950170-25-103004.md) | [137 d](/filings/0001193125-25-264654.md) | [162 d](/filings/0001193125-26-066979.md) | [68.1](/filings/0001193125-26-206311.md) | [(205) d](/filings/0001193125-26-332726.md) | [79.0 d](/filings/0001193125-25-264654.md) | [(14.3) d](/filings/0001193125-26-066979.md) | [67.2](/filings/0001193125-26-206311.md) | [24.6 d](/filings/0001193125-26-332726.md) |
| Share repurchases | $m | [0.0 d](/filings/0000950170-24-122234.md) | [0.0 d](/filings/0001193125-26-066979.md) | [0.0](/filings/0001193125-24-134205.md) | [0.0 d](/filings/0000950170-24-092748.md) | [0.0 d](/filings/0000950170-24-122234.md) | [0.0 d](/filings/0001193125-26-066979.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [54.8](/filings/0001193125-23-272454.md) | [54.6](/filings/0001193125-24-134205.md) | [55.6](/filings/0000950170-24-092748.md) | [54.5](/filings/0000950170-24-122234.md) | [54.6](/filings/0000950170-25-065626.md) | [54.6](/filings/0000950170-25-103004.md) | [54.6](/filings/0001193125-25-264654.md) | [54.6](/filings/0001193125-26-206311.md) | [54.6](/filings/0001193125-26-332726.md) | [54.6](/filings/0001193125-25-264654.md) | [54.6](/filings/0001193125-26-206311.md) | [54.6](/filings/0001193125-26-332726.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 54,554,634 at 2026-07-31, from the cover of the [10-Q filed 2026-08-04](/filings/0001193125-26-332726.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.